MARRIOTT INTERNATIONAL INC /MD/
At today's price, MARRIOTT INTERNATIONAL INC /MD/ (MAR) is priced for +24.0% growth. boothcheck doesn't publish a fair value or a price target; it shows what the price assumes, so you can judge whether that bar is too high. Built from SEC EDGAR filings.
The market is pricing Marriott as a high-quality fee machine, and the fundamentals largely back it: Q1 2026 adjusted EBITDA rose 15% on RevPAR up 4.2%, net rooms grew 4.5%, and the development pipeline hit a record 618,000 rooms. The valuation leaves no cushion. At $396.11 (as of June 27, 2026) no standard method reaches the price, and the embedded bet runs about five years out, so the buyer is paying ahead of every conventional frame. The capital structure is the watch item. Marriott carries
Is MAR overvalued? See what's priced in →
1,589 institutional managers reported holding MAR in 13F filings for the quarter ended 2026-03-31. Together they hold about 58% of the company; the top 10 hold 30%. 160 opened new positions that quarter. Held by Vanguard Group, BlackRock, State Street, among others. On the short side, 6.3M shares were sold short as of the 2026-06-15 count, about 2% of shares outstanding (4.6 days of typical volume to cover).
Quarterly 13F filings arrive up to 45 days after quarter end, so the picture is never current (filed through 2026-05-29). Nothing here is investment advice.
MAR has cut its share count 18.6% over the past five years, spending $14.32B on repurchases. It pays a dividend, and has for 4 years running, raised 3 years straight; the current rate is $2.64 a share annually. Cash returned over the past three years: $1.88B in dividends and $9.67B in repurchases.
Share counts are split-adjusted; repurchase totals are gross of share issuance. Nothing here is investment advice.
No open-market insider buys on file at MAR over the trailing three years. Absence is a fact about the company, not a signal. 25 officers and directors are on file.
Code P open-market purchases from SEC Form 4 filings, non-derivative, excluding scheduled 10b5-1 plans. Nothing here is investment advice.
MAR's recent reports: the day-one move, then what the following quarter actually did.
| report | day one | next quarter |
|---|---|---|
| 2023-08-02 | +0.8% | -4.3% |
| 2023-11-03 | +1.3% | +16.3% |
| 2024-02-14 | -5.4% | +1.3% |
| 2024-05-02 | -0.2% | +2.0% |
Day-one is the close-to-close move around the filing. Nothing here is investment advice.
MAR's latest 8-K filings: 2026-05-13 (items 5.07); 2026-05-06 (items 2.02, 9.01); 2026-02-20 (items 8.01, 9.01); 2026-02-10 (items 2.02, 9.01); 2026-02-06 (items 5.02).
Item codes are the SEC's own classification of what each report discloses. Nothing here is investment advice.
Last analyzed: July 3, 2026
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.